April 21, 2013

Bolton Medical's Relay Plus Thoracic Stent Graft Receives Approval in Japan

April 22, 2013—Earlier this month, Bolton Medical (Sunrise, FL) announced that the Japanese Pharmaceuticals and Medical Devices Agency approved the Relay thoracic stent graft with Plus delivery system. The device is designed to conform in the tortuous anatomy of the thoracic aorta and reduce the potential for stent graft migration and endoleaks after placement. Japan Lifeline Co., Ltd. (Tokyo, Japan) will distribute the device in Japan, according to the company's press release.

Relay is offered in a range of sizes, both in straight and tapered configurations, to adapt to various anatomies. The Plus delivery system has a dual structure consisting of inner and outer sheaths. The hydrophilic coating on the outer sheath allows for smoother manipulation in the vessel, and the soft, flexible inner sheath reduces the potential for trauma to vasculature and facilitates navigation while allowing accurate placement, according to the company. Bolton Medical stent grafts have been available in Europe and other international markets since 2005.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

April 21, 2013

Bolton Medical's Relay Plus Thoracic Stent Graft Receives Approval in Japan

Current Issue

Keep In Touch